K

Kilpest India Ltd
BSE:532067

Watchlist Manager
Kilpest India Ltd
BSE:532067
Watchlist
Price: 798.35 INR 0.56%
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.2B
+5%
Assets
Growth Rates:
1 Year
+9%
3 Years
+39%
5 Years
+570%
7 Years
+769%
10 Years
-
165.7m
-22%
Liabilities
Growth Rates:
1 Year
-64%
3 Years
-69%
5 Years
+29%
7 Years
+13%
10 Years
-
2.1B
+8%
Equity
Growth Rates:
1 Year
+30%
3 Years
+92%
5 Years
+904%
7 Years
+1 765%
10 Years
-

Balance Sheet Decomposition
Kilpest India Ltd

2.2B
Assets
165.7m
Liabilities
2.2B
Assets
165.7m
Liabilities
Current Assets 1.2B
Cash & Short-Term Investments 598.3m
Receivables 362.5m
Other Current Assets 253.3m
Non-Current Assets 1B
Long-Term Investments 956.2m
PP&E 76.8m
Other Non-Current Assets 2.1m
Current Liabilities 102.1m
Accounts Payable 38m
Short-Term Debt 6.1m
Other Current Liabilities 58m
Non-Current Liabilities 63.6m
Long-Term Debt 7.3m
Other Non-Current Liabilities 56.3m

Balance Sheet
Kilpest India Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
4
4
4
4
16
34
94
351
289
592
Cash
0
0
0
3
3
3
3
331
256
532
Cash Equivalents
4
4
4
1
13
31
91
20
33
60
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
Total Receivables
158
167
168
144
165
185
200
349
301
340
Accounts Receivables
128
136
134
142
165
185
199
348
300
339
Other Receivables
30
32
34
2
0
1
1
1
1
1
Inventory
41
40
33
40
37
50
41
49
74
80
Other Current Assets
0
0
0
35
46
52
59
435
152
130
Total Current Assets
203
210
205
223
263
321
393
1 184
815
1 142
PP&E Net
31
28
28
25
35
38
39
51
67
79
PP&E Gross
0
0
0
0
0
0
0
0
0
79
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
52
Intangible Assets
8
8
6
5
4
3
1
0
0
0
Note Receivable
1
1
0
0
2
1
2
3
3
2
Long-Term Investments
0
0
0
3
0
0
12
697
1 036
917
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
242
N/A
247
+2%
241
-2%
257
+6%
304
+19%
363
+20%
448
+23%
1 935
+332%
1 921
-1%
2 141
+11%
Liabilities
Accounts Payable
65
60
47
43
35
39
34
29
35
34
Short-Term Debt
44
51
51
58
35
41
21
10
17
11
Other Current Liabilities
3
5
7
8
17
25
27
390
117
97
Total Current Liabilities
113
116
104
108
87
104
82
430
169
142
Long-Term Debt
25
24
27
29
23
21
15
10
8
9
Deferred Income Tax
7
7
7
7
9
10
10
12
23
29
Minority Interest
2
1
1
0
1
3
21
162
191
31
Other Liabilities
0
0
0
0
0
0
0
0
0
1
Total Liabilities
142
N/A
146
+2%
137
-6%
144
+5%
120
-17%
138
+15%
127
-8%
615
+383%
391
-36%
212
-46%
Equity
Common Stock
64
64
64
64
64
64
75
75
75
86
Retained Earnings
36
37
40
49
120
161
246
1 246
1 455
1 843
Total Equity
100
N/A
101
+2%
104
+3%
112
+8%
184
+63%
225
+22%
321
+43%
1 321
+311%
1 530
+16%
1 928
+26%
Total Liabilities & Equity
242
N/A
247
+2%
241
-2%
257
+6%
304
+19%
363
+20%
448
+23%
1 935
+332%
1 921
-1%
2 141
+11%
Shares Outstanding
Common Shares Outstanding
6
6
6
6
6
6
8
8
8
8

See Also

Summary
3BBLACKBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
3BBLACKBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
3BBLACKBIO stock valuation using valuation multiples.
Wall Street Estimates
3BBLACKBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
3BBLACKBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.